1. Home
  2. IT vs JAZZ Comparison

IT vs JAZZ Comparison

Compare IT & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gartner Inc.

IT

Gartner Inc.

HOLD

Current Price

$143.46

Market Cap

11.0B

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$194.74

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IT
JAZZ
Founded
1979
2003
Country
United States
Ireland
Employees
40
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
10.4B
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
IT
JAZZ
Price
$143.46
$194.74
Analyst Decision
Hold
Strong Buy
Analyst Count
9
13
Target Price
$216.63
$216.92
AVG Volume (30 Days)
1.3M
734.6K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
9.65
N/A
Revenue
$2,021,441,000.00
$1,618,693,000.00
Revenue This Year
$3.64
$6.13
Revenue Next Year
$5.12
$7.75
P/E Ratio
$14.87
N/A
Revenue Growth
13.30
N/A
52 Week Low
$139.18
$98.96
52 Week High
$451.73
$200.24

Technical Indicators

Market Signals
Indicator
IT
JAZZ
Relative Strength Index (RSI) 34.63 62.56
Support Level $142.32 $159.78
Resistance Level $163.50 $198.00
Average True Range (ATR) 7.02 4.92
MACD -0.54 0.83
Stochastic Oscillator 7.53 72.14

Price Performance

Historical Comparison
IT
JAZZ

About IT Gartner Inc.

Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: